Literature DB >> 29443184

Complementary and alternative medicine in multiple sclerosis: Payment policy perspectives.

Heidi Moawad1, Katie M Shepard1, Saty Satya-Murti1.   

Abstract

This article identifies payment policy perspectives of the American Academy of Neurology's guideline on complementary and alternative medicine (CAM) in multiple sclerosis (MS). The guideline is a reliable repository of information for advocating or not recommending certain CAM treatments in MS. It eases the burden of searching for information on each separate CAM treatment. It frequently emphasizes the need for patient counseling. To provide such generally undervalued, but needed, cognitive services, neurologists could use advanced practice providers and patient-friendly visual aids during or between visits. They should also rely on evaluation and management codes that recognize time spent predominantly on counseling or coordination of care. The guideline's categorization of probable effectiveness of certain therapies will not influence coverage decisions because payers do not generally cover CAM therapies.

Entities:  

Year:  2015        PMID: 29443184      PMCID: PMC5764430          DOI: 10.1212/CPJ.0000000000000020

Source DB:  PubMed          Journal:  Neurol Clin Pract        ISSN: 2163-0402


  10 in total

1.  Complementary and alternative medicine use among US adults with common neurological conditions.

Authors:  Rebecca Erwin Wells; Russell S Phillips; Steven C Schachter; Ellen P McCarthy
Journal:  J Neurol       Date:  2010-06-11       Impact factor: 4.849

2.  Cannabis--a valuable drug that deserves better treatment.

Authors:  Raphael Mechoulam
Journal:  Mayo Clin Proc       Date:  2012-02       Impact factor: 7.616

Review 3.  Blurred boundaries: the therapeutics and politics of medical marijuana.

Authors:  J Michael Bostwick
Journal:  Mayo Clin Proc       Date:  2012-02       Impact factor: 7.616

4.  Perspectives on complementary and alternative medicine research.

Authors:  Josephine P Briggs; Jack Killen
Journal:  JAMA       Date:  2013-08-21       Impact factor: 56.272

5.  Smoking and disease progression in multiple sclerosis.

Authors:  Brian C Healy; Eman N Ali; Charles R G Guttmann; Tanuja Chitnis; Bonnie I Glanz; Guy Buckle; Maria Houtchens; Lynn Stazzone; Jennifer Moodie; Annika M Berger; Yang Duan; Rohit Bakshi; Samia Khoury; Howard Weiner; Alberto Ascherio
Journal:  Arch Neurol       Date:  2009-07

Review 6.  A systematic review of randomized, double-blind, placebo-controlled trials examining the clinical efficacy of vitamin D in multiple sclerosis.

Authors:  Beatriz Pozuelo-Moyano; Julián Benito-León; Alex J Mitchell; Jesús Hernández-Gallego
Journal:  Neuroepidemiology       Date:  2012-12-18       Impact factor: 3.282

7.  Use of complementary and alternative medicine practitioners by people with physical disabilities: estimates from a National US Survey.

Authors:  Matthew J Carlson; Gloria Krahn
Journal:  Disabil Rehabil       Date:  2006-04-30       Impact factor: 3.033

8.  Summary of evidence-based guideline: complementary and alternative medicine in multiple sclerosis: report of the guideline development subcommittee of the American Academy of Neurology.

Authors:  Vijayshree Yadav; Christopher Bever; James Bowen; Allen Bowling; Bianca Weinstock-Guttman; Michelle Cameron; Dennis Bourdette; Gary S Gronseth; Pushpa Narayanaswami
Journal:  Neurology       Date:  2014-03-25       Impact factor: 9.910

9.  Acupuncture Use among American Adults: What Acupuncture Practitioners Can Learn from National Health Interview Survey 2007?

Authors:  Yan Zhang; Lixing Lao; Haiyan Chen; Rodrigo Ceballos
Journal:  Evid Based Complement Alternat Med       Date:  2012-02-22       Impact factor: 2.629

10.  Tobacco smoking and disability progression in multiple sclerosis: United Kingdom cohort study.

Authors:  Ali Manouchehrinia; Christopher R Tench; Jonathan Maxted; Rashid H Bibani; John Britton; Cris S Constantinescu
Journal:  Brain       Date:  2013-06-11       Impact factor: 13.501

  10 in total
  2 in total

Review 1.  Phytochemicals as inhibitors of tumor necrosis factor alpha and neuroinflammatory responses in neurodegenerative diseases.

Authors:  Fatemeh Zahedipour; Seyede Atefe Hosseini; Neil C Henney; George E Barreto; Amirhossein Sahebkar
Journal:  Neural Regen Res       Date:  2022-08       Impact factor: 5.135

2.  Sources of Cannabis Information and Medical Guidance for Neurologic Use: NARCOMS Survey of People Living With Multiple Sclerosis.

Authors:  Amber Salter; Gary Cutter; Ruth Ann Marrie; Kathryn Nichol; Joshua R Steinerman; Karry M J Smith; Robert J Fox
Journal:  Neurol Clin Pract       Date:  2022-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.